Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Methylthioninium

EU orphan designation number: EU/3/10/805   
Active ingredient: Methylthioninium
Indication: Treatment of behavioural variant frontotemporal dementia
Sponsor: Prof. Claude Wischik
TauRx Therapeutics, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Centralised Orphan - Designation EMA/OD/063/10 (2010)8589 of 26/11/2010
17/02/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/063/10/T/01 (2012)1105 of 15/02/2012